5
Participants
Start Date
March 25, 2016
Primary Completion Date
August 6, 2019
Study Completion Date
August 6, 2019
GL-ONC1
"Dose and Regimen:~1. Single dose group: Cohort 1 dose is 1 × 109 pfu~2. Multiple dose groups:~ * Cohort 2 dose is 1 × 109 pfu × 5 consecutive days~ * Cohorts 3 and 4 dose is 2 × 109 pfu × 5 consecutive days~ * Cohorts 5 and 6 dose escalates at 2,3,5,5,5 × 109 pfu.~Route: GL-ONC1 is delivered as a bolus IV injection."
UC San Diego Moores Cancer Center, La Jolla
Collaborators (1)
Genelux Corporation
INDUSTRY
Andrew Lowy
OTHER